Recombinant human interleukin-3(Shenyang Sunshine Pharmaceutical)
注射用重组人白细胞介素-3（沈阳三生制药）
Report date: 2022/01/17 12:14:22
Base Information
Drug NameRecombinant human interleukin-3(Shenyang Sunshine Pharmaceutical)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusDiscontinued (NDA/BLA)
Highest Status in ChinaDiscontinued
Originator CompaniesShenyang Sunshine Pharmaceutical Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesShenyang Sunshine Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A